Peter Attia· MD
Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and it's the single most important thing that you can do in the plasma to reduce the risk of atherosclerotic disease
and the longer you wait the more it puts the burden on you to really lower that apob
pharmacologically lower apob to somewhere in the 20 to 30 milligram per deciliter range for everybody in the population while someone is in their 20s can you eliminate ascvd and I think the answer is probably yes in other words I think what you're basically going to do is eliminate death from atherosclerotic causes and that would need to be started in 20s I think